VKH
CRVO icon

Virtu KCG Holdings’s CervoMed CRVO Stock Holding History

Virtu KCG Holdings’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$38K Buy
15
+1
+7% +$3.22K ﹤0.01% 2646
2017
Q1 		$64K Buy
+14
New +$60.1K ﹤0.01% 2786

Other funds holding CRVO

SRCM
Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Signature Financial Management Norfolk, Virginia $416M AUM 8.59% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Virtu KCG Holdings's CRVO Position: Q2 2017 in Review

Virtu KCG Holdings increased its CervoMed (CRVO) stake by 7.1% in Q2 2017, buying an estimated $3.22K and bringing the position to 15 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Virtu KCG Holdings first reported a position in CRVO in Q1 2017 and has held it in 2 quarters since. The position peaked at $64K in Q1 2017. 10 funds tracked by Wall St. Rank hold CRVO as of Q2 2017.

  • Virtu KCG Holdings held 15 shares of CervoMed worth $38K as of Q2 2017.
  • Virtu KCG Holdings bought 1 CervoMed share in Q2 2017, an estimated $3.22K.
  • CervoMed made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2646 holding.
  • Virtu KCG Holdings first reported a position in CervoMed in Q1 2017 and has held it in 2 quarters since.
  • Virtu KCG Holdings's CervoMed position peaked at $64K in Q1 2017.
  • 10 funds tracked by Wall St. Rank held CervoMed as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.